Standard Nuclear, Inc. (STDN): Results of Operations and Financial Condition
Standard Nuclear, Inc. (STDN) filed an SEC Form 8-K — Results of Operations and Financial Condition. FOR IMMEDIATE RELEASE August 26, 2026 Standard Nuclear Reports Second Quarter and Year-to-Date 2026 Results Total Contract Backlog Grows Six-Fold Since March 31 to $576.9 Million as Qualified Pipeline Converts to Long-Term Contracts • Generated $4.7 million of revenue in the seco
How this was made
The 30-second read
Why it matters
The earnings release provides fresh quantitative data on revenue, backlog, and operational milestones, offering a clear catalyst for short‑term trading decisions.
Market read
The filing underscores rapid growth in a niche nuclear fuel market, with potential spillover effects for related energy and defense sectors.
What to watch
Regulatory approvals for HALEU fuel and potential DOE contract delays could affect execution.
Standard Nuclear Reports Second Quarter and Year-to-Date 2026 Results; Total Contract Backlog Grows to $576.9 Million Giving Effect to the August 2026 Fuel Supply Agreement
The quarter delivered first commercial product revenue and a first quarterly gross profit, alongside sharp growth in funded and total contract backlog. However, the company remained loss-making as public-company infrastructure, production scale-up, and facility-authorization work increased costs, and new-facility operation remains targeted for the fourth quarter of 2026.
Key metrics
as reported| Metric | Value | q/q | y/y |
|---|---|---|---|
| Total revenue, three months ended June 30, 2026GAAP | $4,735,791 | – | increased $4.1 million |
| Product revenue, three months ended June 30, 2026GAAP | $3,100,000 | – | – |
| Service revenue, three months ended June 30, 2026GAAP | $1,635,791 | – | – |
| Cost of revenue, three months ended June 30, 2026GAAP | $1,552,797 | – | increased $0.4 million |
| Gross profit (loss), three months ended June 30, 2026GAAP | $3,182,994 | – | first quarter of gross profit |
| General and administrative costs, three months ended June 30, 2026GAAP | $5,520,577 | – | increased $4.5 million |
| Research and development expenses, three months ended June 30, 2026GAAP | $1,957,895 | – | – |
| Loss from operations, three months ended June 30, 2026GAAP | $(4,295,478) | – | increased $2.7 million |
| Interest income, three months ended June 30, 2026GAAP | $(877,693) | – | – |
| Other expense (income), three months ended June 30, 2026GAAP | $— | – | – |
| Net loss, three months ended June 30, 2026GAAP | $(3,417,785) | decreased sequentially to $3.4 million from $7.7 million | increased $1.8 million |
| Basic and diluted net loss per share, three months ended June 30, 2026GAAP | $(0.12) | – | – |
| Weighted average common shares outstanding, basic and diluted, three months ended June 30, 2026GAAP | 28,001,802 | – | – |
| Total revenue, six months ended June 30, 2026GAAP | $5,329,593 | – | increased $4.4 million |
| Product revenue, six months ended June 30, 2026GAAP | $3,101,741 | – | – |
| Service revenue, six months ended June 30, 2026GAAP | $2,227,852 | – | – |
| Cost of revenue, six months ended June 30, 2026GAAP | $6,558,803 | – | increased $4.3 million |
| Gross profit (loss), six months ended June 30, 2026GAAP | $(1,229,210) | – | – |
| General and administrative costs, six months ended June 30, 2026GAAP | $9,352,625 | – | increased $7.8 million |
| Research and development expenses, six months ended June 30, 2026GAAP | $1,957,895 | – | – |
| Loss from operations, six months ended June 30, 2026GAAP | $(12,539,730) | – | increased $9.4 million |
| Increase in fair value of SAFE Notes, six months ended June 30, 2026GAAP | $— | – | – |
| Gain on extinguishment of debt, six months ended June 30, 2026GAAP | $— | – | – |
| Interest income, six months ended June 30, 2026GAAP | $(1,406,994) | – | – |
| Other expense (income), six months ended June 30, 2026GAAP | $— | – | – |
| Net loss, six months ended June 30, 2026GAAP | $(11,132,736) | – | increased $1.2 million |
| Basic and diluted net loss per share, six months ended June 30, 2026GAAP | $(0.40) | – | – |
| Weighted average common shares outstanding, basic and diluted, six months ended June 30, 2026GAAP | 28,000,906 | – | – |
| Total Contract Backlog, June 30, 2026other | $241.5 million | grew to $241.5 million from $91.3 million | – |
| Funded Backlog, June 30, 2026other | $61.9 million | grew from $8.2 million to $61.9 million | – |
| Purchase Options under Executed Contracts, June 30, 2026other | $156.5 million | – | – |
| Unfunded Backlog, June 30, 2026other | $23.1 million | – | – |
| Qualified Pipeline, June 30, 2026other | $986.3 million | – | – |
| Total Contract Backlog, August 26, 2026other | $576.9 million | – | – |
| Funded Backlog, August 26, 2026other | $119.3 million | increased approximately 93% to $119.3 million | – |
| Purchase Options under Executed Contracts, August 26, 2026other | $443.5 million | – | – |
| Unfunded Backlog, August 26, 2026other | $14.1 million | decreased to $14.1 million from $23.1 million | – |
| Qualified Pipeline, August 26, 2026other | $696.3 million | decreased from approximately $986.3 million to approximately $696.3 million | – |
Segments
| Segment | Revenue | q/q | y/y |
|---|---|---|---|
| Product RevenueDeliveries of TRISO under one fuel supply agreement, including the Company's first commercial delivery. | $3,100,000 | – | – |
| Service RevenueWork performed under fuel development contracts and research and development projects performed for U.S. government agencies. | $1,635,791 | – | – |
Fourth quarter of 2026 and operational capacity targets outlook
- NoteAuthorization to operate at both SN-TN and SN-ID is targeted for the fourth quarter of 2026.
- NoteSN-TN and SN-ID each start at up to one MTU per year and are designed to scale to 2.5 MTU each, for combined capacity of up to five MTU per year.
- NoteSN-0 has capacity of up to 0.5 MTU annually.
- NoteThe Framatome joint venture is expected to begin production at the Richland site in 2027, with initial capacity expected of approximately one MTU of TRISO fuel annually and ability to expand to two MTU.
What drove it
- Second-quarter revenue included $3.1 million of product revenue from TRISO deliveries under one fuel supply agreement, including the first commercial delivery.
- The company delivered 50 kgU of TRISO fuel to Radiant Industries during the second quarter and delivered the balance of the reactor core subsequent to quarter end.
- Second-quarter gross profit reflected first commercial product deliveries.
- Second-quarter cost of revenue increased as SN-0 production operations scaled up while the company qualified processes and manufactured its first commercial core.
- General and administrative cost growth reflected share-based compensation, third-party consulting related to the public-company transition, and payroll and benefit costs.
- Research and development spending supported manufacturing-process qualification and licensing and authorization deliverables for SN-TN and SN-ID.
- Backlog growth reflected conversion of qualified-pipeline opportunities and non-binding arrangements into executed contracts.
- The August agreement with Antares Nuclear included a firm commitment for one MTU of HALEU TRISO fuel and a customer option for up to seven additional MTU over the next several years.
Concerns
- Total Contract Backlog includes unexercised customer options and non-binding arrangements, is not a measure of contracted revenue, and should not be relied upon as an indicator of future results.
- Funded Backlog was $61.9 million at June 30, 2026, compared with Total Contract Backlog of $241.5 million, while purchase options and unfunded backlog comprised the balance.
- The company reported a $3.4 million second-quarter net loss and a $11.1 million six-month net loss.
- The six-month period had a $1.2 million gross loss because first-quarter process-qualification and production-scale-up costs lacked corresponding commercial product deliveries.
- SN-TN and SN-ID had construction substantially complete but remained in start-up, commissioning, and authorization activities, with authorization to operate targeted for the fourth quarter of 2026.
- DOE selection for advanced contract negotiations under the Surplus Plutonium Utilization Program does not constitute a contract award.
- Per-share amounts use the pre-IPO capital structure and are not comparable with periods following the IPO, after which approximately 154.2 million shares of common stock were outstanding.
What to watch
- Authorization progress and the fourth-quarter 2026 target to operate SN-TN and SN-ID.
- Conversion of $443.5 million of Purchase Options under Executed Contracts and $14.1 million of Unfunded Backlog as of August 26, 2026 into binding fuel sales.
- Execution against the Antares Nuclear fuel supply agreement and the timing of deliveries under Radiant Industries agreements.
- Whether commercial production revenue from new facilities offsets ongoing production scale-up, facility qualification, and public-company costs.
- The planned 2027 start of TRISO-based fuel production at the Framatome joint venture's Richland facility.
Balance sheet and cash flow
- Cash and cash equivalents were $102,185,333 at June 30, 2026, compared with $63,101,704 at December 31, 2025.
- Accounts receivable and contract assets, net were $8,128,817 at June 30, 2026, compared with $2,291,669 at December 31, 2025.
- Property and equipment, net were $31,375,038 at June 30, 2026, compared with $12,627,624 at December 31, 2025.
- Investment in Joint Venture was $2,481,829 at June 30, 2026, compared with $1,130,170 at December 31, 2025.
- Total assets were $146,953,077 at June 30, 2026, compared with $79,151,167 at December 31, 2025.
- Total current liabilities were $8,747,548 at June 30, 2026, compared with $3,513,679 at December 31, 2025.
- Total liabilities were $9,542,802 at June 30, 2026, compared with $4,266,902 at December 31, 2025.
- The July 17, 2026 initial public offering generated approximately $137.7 million of net proceeds.
- The company reported approximately $239.9 million of pro forma cash and a debt-free balance sheet following the IPO.
- Operating cash flow and free cash flow were not reported in the filing text.
Analysis
Standard Nuclear's second quarter marked its first commercial product-revenue quarter. Revenue was $4.7 million, compared with $0.6 million in the prior-year period, driven principally by $3.1 million of TRISO product revenue under one fuel supply agreement. The company delivered 50 kgU to Radiant Industries during the quarter and completed delivery of the remaining reactor core after quarter end. This activity shifted quarterly gross profit to $3.2 million from a gross loss of $0.6 million a year earlier.
The improvement in gross profit did not yet translate to operating profitability. General and administrative costs were $5.5 million, up from $1.0 million, reflecting public-company infrastructure, consulting, share-based compensation, and payroll. Research and development expense was $2.0 million for process qualification and facility authorization. The result was a $4.3 million operating loss and a $3.4 million net loss. Net loss nevertheless improved sequentially from $7.7 million in the first quarter, primarily due to the first commercial product revenue.
Demand indicators strengthened materially through contracts signed in and after the quarter. Total Contract Backlog was $241.5 million at June 30, 2026, versus $91.3 million at March 31, and Funded Backlog was $61.9 million versus $8.2 million. Giving effect to the August Antares Nuclear agreement, Total Contract Backlog reached $576.9 million, including $119.3 million of Funded Backlog and $443.5 million of Purchase Options under Executed Contracts. The filing explicitly cautions that total backlog includes unexercised options and non-binding arrangements and should not be treated as contracted revenue.
Capacity execution is the core operational milestone. SN-TN and SN-ID construction is substantially complete, but both remain in commissioning and authorization work, with authorization to operate targeted for the fourth quarter of 2026. Each facility starts at up to one MTU per year and is designed to scale to 2.5 MTU, while SN-0 continues to have capacity of up to 0.5 MTU annually. Separately, the Framatome joint venture received an NRC license amendment that clears its regulatory path to begin production in 2027, subject to the stated plan.
Liquidity increased following the IPO. Cash and cash equivalents were $102.2 million at June 30, before the July offering generated approximately $137.7 million of net proceeds. Management cited approximately $239.9 million of pro forma cash and a debt-free balance sheet. No financial revenue, margin, expense, or tax-rate outlook was provided; the stated forward milestones center on fourth-quarter facility authorization and the future ramp of production capacity.
Management, verbatim
Standard Nuclear is currently the only independent U.S. company producing TRISO fuel at scale for commercial customers across diverse applications. In the second quarter we made our first commercial delivery and we completed our first reactor core shortly after quarter end.
Kurt Terrani, President and Chief Executive Officer
What this quarter demonstrates is conversion. Total Contract Backlog grew to $241.5 million at June 30 from $91.3 million at March 31, and to $576.9 million giving effect to the August 2026 fuel supply agreement.
Kevin Harrill, Chief Financial Officer
Not in the filing
stated, not guessed- Prior quarterly outlook was not provided.
- Financial guidance for revenue, gross margin, operating expenses, tax rate, earnings, cash flow, or capital expenditures was not provided.
- Non-GAAP financial measures, including non-GAAP EPS, were not reported.
- Gross margin was not reported.
- Operating cash flow was not reported.
- Free cash flow was not reported.
- Share repurchases and dividends were not reported.
- A complete March 31, 2026 Unfunded Backlog figure was not reliably presented in the filing text; the relevant table and narrative contain malformed values.
- Segment reporting beyond product revenue and service revenue was not provided.
AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.
Background
Standard Nuclear, a newly public NYSE company, provides TRISO nuclear fuel for advanced reactors. The 8‑K filing is its first quarterly earnings release after its July IPO.
Ticker impact
Standard Nuclear filed its 8‑K earnings report showing Q2 revenue of $4.7 M, a six‑fold backlog increase to $576.9 M and completion of its first commercial TRISO fuel core.
Potential intraday rally of 5‑10% as investors price in strong order book and operational milestones.
The disclosed financials and contract wins are material for a micro‑cap, and the filing is the first public source of this data.
Market effects
Highlights growing demand for TRISO nuclear fuel, potentially benefitting other niche nuclear fuel suppliers.
Strengthens the U.S. advanced nuclear manufacturing sector, especially in Tennessee and Idaho.
Signals progress in HALEU fuel supply, relevant for global nuclear reactor developers.
Counterpoint
Backlog growth may be overstated if future contracts are not fully funded; cash burn could pressure the balance sheet.
Key entities
- CompanyStandard Nuclear, Inc.
TRISO nuclear fuel producer listed on NYSE under ticker STDN.
- Government AgencyU.S. Department of Energy
Selected Standard Nuclear for advanced contract negotiations under the Surplus Plutonium Utilization Program.
